357 related articles for article (PubMed ID: 15682657)
41. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
[TBL] [Abstract][Full Text] [Related]
42. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
44. [Detection of hepatitis C virus-C, E, NS3 and NS4 regions' antigens in hepatocellular carcinoma and liver cirrhosis].
Wang L; Li D; Lang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):326-9. PubMed ID: 12526345
[TBL] [Abstract][Full Text] [Related]
45. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA
Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
[TBL] [Abstract][Full Text] [Related]
46. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
47. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.
Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U
Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360
[TBL] [Abstract][Full Text] [Related]
49. [Serum hepatitis B antigen-antibody system in patients with hepatocellular carcinoma].
Wu A; Cheng G
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):441-3. PubMed ID: 8697998
[TBL] [Abstract][Full Text] [Related]
50. Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Raedle J; Oremek G; Roth WK; Caspary WF; Zeuzem S
Anticancer Res; 1997; 17(4B):3079-81. PubMed ID: 9329606
[TBL] [Abstract][Full Text] [Related]
51. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for hepatocellular carcinoma in Southern Iran.
Hajiani E; Masjedizadeh R; Hashemi J; Azmi M; Rajabi T
Saudi Med J; 2005 Jun; 26(6):974-7. PubMed ID: 15983686
[TBL] [Abstract][Full Text] [Related]
53. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
54. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Thambyrajah V; Balasegaram M; Satgunasingam N
Br J Biomed Sci; 1994 Jun; 51(2):177-80. PubMed ID: 7519505
[TBL] [Abstract][Full Text] [Related]
56. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
57. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
Lin F; Abdallah H; Meschter S
Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
[TBL] [Abstract][Full Text] [Related]
59. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]